Skip to main content

Bruker Completes Acquisition of Varian Product Lines

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker said after the close of the market Wednesday that it has completed the acquisition of three product lines from Varian, which was acquired by Agilent last week.

The product lines include Varian's global inductively coupled plasma mass spectrometry instruments business; its global laboratory gas chromatography instruments business; and its global gas chromatography triple-quadrupole mass spectrometry instruments business. As part of the deal between Agilent and Bruker, the firms entered into a transitional services and supply agreement to facilitate uninterrupted delivery of the products and services associated with the product lines.

Bruker signed the deal to acquire the product lines in March.

The sale was a condition of regulatory clearance by European Union authorities of Agilent's $1.5 billion bid to acquire Varian.

"This acquisition offers an opportunity to leverage our existing technology, applications and customer support strengths in scientific instruments," Bruker President and CEO Frank Laukien said in a statement. "The three new product lines perfectly complement our existing mass spectrometry products, and will further strengthen Bruker's position in many industrial and applied markets with an expanded portfolio."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.